OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders
Anindya Bhattacharya, Declan N.C. Jones
Psychoneuroendocrinology (2018) Vol. 98, pp. 95-100
Closed Access | Times Cited: 88

Showing 26-50 of 88 citing articles:

Effect of P2X7 receptor on tumorigenesis and its pharmacological properties
Wenjun Zhang, Cegui Hu, Jinfeng Zhu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 125, pp. 109844-109844
Open Access | Times Cited: 44

P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
Paul R. Territo, Hamideh Zarrinmayeh
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 37

High, in Contrast to Low Levels of Acute Stress Induce Depressive-like Behavior by Involving Astrocytic, in Addition to Microglial P2X7 Receptors in the Rodent Hippocampus
Yafei Zhao, Wenjing Ren, Ying Zhang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1904-1904
Open Access | Times Cited: 26

P2X7 receptors from the perspective of NLRP3 inflammasome pathway in depression: Potential role of cannabidiol
Elif Akçay, Hülya Karataş
Brain Behavior & Immunity - Health (2024) Vol. 41, pp. 100853-100853
Open Access | Times Cited: 5

The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Péter Illés, Patrizia Rubini, Lumei Huang, et al.
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 3, pp. 165-176
Closed Access | Times Cited: 42

P2X7R antagonists in chronic stress-based depression models: a review
Iven-Alex von Muecke-Heim, Clemens Ries, Lidia Urbina-Treviño, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 271, Iss. 7, pp. 1343-1358
Open Access | Times Cited: 32

Crosstalk Between ATP-P2X7 and Adenosine A2A Receptors Controlling Neuroinflammation in Rats Subject to Repeated Restraint Stress
Liliana Dias, Cátia R. Lopes, Francisco Q. Gonçalves, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 30

Inhibition of Microglial NLRP3 with MCC950 Attenuates Microglial Morphology and NLRP3/Caspase-1/IL-1β Signaling In Stress-induced Mice
Qing Liu, Manman Zhang, Min-Xia Guo, et al.
Journal of Neuroimmune Pharmacology (2022) Vol. 17, Iss. 3-4, pp. 503-514
Closed Access | Times Cited: 22

Aluminum induces neuroinflammation via P2X7 receptor activating NLRP3 inflammasome pathway
Xiaoying Zhu, Wudi Hao, Ziyue Liu, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 249, pp. 114373-114373
Open Access | Times Cited: 21

Establishment and behavioural characterization of a novel constitutive P2X7 receptor knockout mouse line
Iven-Alex von Mücke-Heim, Judit Oldekamp, Michael Metzger, et al.
Purinergic Signalling (2025)
Open Access

Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior
Giorgia Moschetti, Giada Amodeo, Maria Serena Paladini, et al.
Brain Behavior and Immunity (2019) Vol. 82, pp. 422-431
Open Access | Times Cited: 35

Antidepressant-like effect induced by P2X7 receptor blockade in FSL rats is associated with BDNF signalling activation
Deidiane Elisa Ribeiro, Heidi Kaastrup Müller, Betina Elfving, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 11, pp. 1436-1446
Closed Access | Times Cited: 34

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
Knut Biber, Anindya Bhattacharya, Brian Campbell, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 32

Impaired ATP Release from Brain Astrocytes May be a Cause of Major Depression
Péter Illés, Patrizia Rubini, Haiyan Yin, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 11, pp. 1281-1284
Open Access | Times Cited: 29

Association of DNA Methylation of the NLRP3 Gene with Changes in Cortical Thickness in Major Depressive Disorder
Kyu‐Man Han, Kwan Woo Choi, Aram Kim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5768-5768
Open Access | Times Cited: 18

Platelets and the Role of P2X Receptors in Nociception, Pain, Neuronal Toxicity and Thromboinflammation
Elias Rawish, Harald F. Langer
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6585-6585
Open Access | Times Cited: 18

P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex
Wenjing Ren, Yafei Zhao, Jie Li, et al.
Cerebral Cortex (2023) Vol. 33, Iss. 14, pp. 8858-8875
Closed Access | Times Cited: 9

Is There such a Thing as Post-Viral Depression?: Implications for Precision Medicine
Eun‐Sook Park, Chan Young Shin, Se Jin Jeon, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 6, pp. 659-684
Closed Access | Times Cited: 3

The ligand-gated ion channel P2X7 receptor mediates NLRP3/caspase-1-mediated pyroptosis in cerebral cortical neurons of juvenile rats with sepsis
Xuemei Sun, Ruixi Zhou, Yupeng Lei, et al.
Brain Research (2020) Vol. 1748, pp. 147109-147109
Open Access | Times Cited: 27

NLRP1-Mediated Antidepressant Effect of Ketamine in Chronic Unpredictable Mild Stress Model in Rats
Feyza Arıcıoğlu, Canan Yalcinkaya, Ceren Şahin Özkartal, et al.
Psychiatry Investigation (2020) Vol. 17, Iss. 4, pp. 283-291
Open Access | Times Cited: 24

Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches
Rakesh Kumar Singh
Current Neuropharmacology (2020) Vol. 18, Iss. 9, pp. 868-882
Open Access | Times Cited: 23

P2X7 receptor antagonists for the treatment of systemic inflammatory disorders
Christine F. Gelin, Anindya Bhattacharya, Michael A. Letavic
Progress in medicinal chemistry (2020), pp. 63-99
Closed Access | Times Cited: 22

Altered Purinergic Signaling in Neurodevelopmental Disorders: Focus on P2 Receptors
Marta Boccazzi, Stefano Raffaele, Thomas Zanettin, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 856-856
Open Access | Times Cited: 7

Scroll to top